
Page#1
Table of Contents
MetLife, Inc.
Consolidated Balance Sheets
December 31, 2017 and 2016
(In millions, except share and per share data)
2017 2016
Assets
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $286,069 and $271,676, respectively) $ 308,931 $ 289,563
Equity securities available-for-sale, at estimated fair value (cost: $2,140 and $2,464, respectively) 2,513 2,894
Fair value option securities, at estimated fair value ($6 and $8, respectively, relating to variable interest entities) 16,745 13,923
Mortgage loans (net of valuation allowances of $314 and $304, respectively; includes $520 and $566, respectively, under the fair value option) 68,731 65,167
Policy loans 9,669 9,511
Real estate and real estate joint ventures (includes $25 and $59, respectively, of real estate held-for-sale) 9,637 8,891
Other limited partnership interests (includes $0 and $14, respectively, relating to variable interest entities) 5,708 5,136
Short-term investments, principally at estimated fair value 4,870 6,523
Other invested assets (includes $125 and $31, respectively, relating to variable interest entities) 17,263 19,303
Total investments 444,067 420,911
Cash and cash equivalents, principally at estimated fair value (includes $12 and $1, respectively, relating to variable interest entities) 12,701 12,651
Accrued investment income 3,524 3,308
Premiums, reinsurance and other receivables (includes $3 and $2, respectively, relating to variable interest entities) 18,423 15,445
Deferred policy acquisition costs and value of business acquired 18,419 17,590
Current income tax recoverable — 20
Goodwill 9,590 9,220
Assets of disposed subsidiary — 216,983
Other assets (includes $2 and $3, respectively, relating to variable interest entities) 8,167 7,058
Separate account assets 205,001 195,578
Total assets $ 719,892 $ 898,764
Liabilities and Equity
Liabilities
Future policy benefits $ 177,974 $ 166,636
Policyholder account balances 182,518 172,486
Other policy-related balances 15,515 13,402
Policyholder dividends payable 682 696
Policyholder dividend obligation 2,121 1,931
Payables for collateral under securities loaned and other transactions 25,723 25,873
Short-term debt 477 242
Long-term debt (includes $6 and $12, respectively, at estimated fair value, relating to variable interest entities) 15,686 16,441
Collateral financing arrangement 1,121 1,274
Junior subordinated debt securities 3,144 3,169
Liabilities of disposed subsidiary — 202,707
Current income tax payable 311 —
Deferred income tax liability 6,767 6,892
Other liabilities (includes $3 and $0, respectively, relating to variable interest entities) 23,982 23,735
Separate account liabilities 205,001 195,578
Total liabilities 661,022 831,062
Contingencies, Commitments and Guarantees (Note 20)
Equity
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value $0.01 per share; $2,100 aggregate liquidation preference — —
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,168,710,101 and 1,164,029,985 shares issued, respectively;
1,043,588,396 and 1,095,519,005 shares outstanding, respectively 12 12
Additional paid-in capital 31,111 30,944
Retained earnings 26,527 34,683
Treasury stock, at cost; 125,121,705 and 68,510,980 shares, respectively (6,401) (3,474)
Accumulated other comprehensive income (loss) 7,427 5,366
Total MetLife, Inc.’s stockholders’ equity 58,676 67,531
Noncontrolling interests 194 171
Total equity 58,870 67,702
Total liabilities and equity $ 719,892 $ 898,764
See accompanying notes to the consolidated financial statements.
202
Page#2
Table of Contents
MetLife, Inc.
Consolidated Statements of Operations
For the Years Ended December 31, 2017, 2016 and 2015
(In millions, except per share data)
2017 2016 2015
Revenues
Premiums $ 38,992 $ 37,202 $ 36,403
Universal life and investment-type product policy fees 5,510 5,483 5,570
Net investment income 17,363 16,790 16,205
Other revenues 1,341 1,685 1,927
Net investment gains (losses):
Other-than-temporary impairments on fixed maturity securities (11) (96) (61)
Other-than-temporary impairments on fixed maturity securities transferred to other
comprehensive income (loss) 1 (11) 2
Other net investment gains (losses) (298) 424 668
Total net investment gains (losses) (308) 317 609
Net derivative gains (losses) (590) (690) 629
Total revenues 62,308 60,787 61,343
Expenses
Policyholder benefits and claims 38,313 36,358 35,144
Interest credited to policyholder account balances 5,607 5,176 4,415
Policyholder dividends 1,231 1,223 1,356
Other expenses 13,621 13,749 14,777
Total expenses 58,772 56,506 55,692
Income (loss) from continuing operations before provision for income tax 3,536 4,281 5,651
Provision for income tax expense (benefit) (1,470) 693 1,590
Income (loss) from continuing operations, net of income tax 5,006 3,588 4,061
Income (loss) from discontinued operations, net of income tax (986) (2,734) 1,324
Net income (loss) 4,020 854 5,385
Less: Net income (loss) attributable to noncontrolling interests 10 4 12
Net income (loss) attributable to MetLife, Inc. 4,010 850 5,373
Less: Preferred stock dividends 103 103 116
Preferred stock repurchase premium — — 42
Net income (loss) available to MetLife, Inc.’s common shareholders $ 3,907 $ 747 $ 5,215
Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s
common shareholders per common share:
Basic $ 4.57 $ 3.16 $ 3.48
Diluted $ 4.53 $ 3.13 $ 3.44
Net income (loss) available to MetLife, Inc.’s common shareholders per common share:
Basic $ 3.65 $ 0.68 $ 4.67
Diluted $ 3.62 $ 0.67 $ 4.62
Cash dividends declared per common share $ 1.600 $ 1.575 $ 1.475
See accompanying notes to the consolidated financial statements.
203
Page#3
Table of Contents
MetLife, Inc.
Consolidated Statements of Cash Flows
For the Years Ended December 31, 2017, 2016 and 2015
(In millions)
2017 2016 2015
Cash flows from operating activities
Net income (loss) $ 4,020 $ 854 $ 5,385
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization expenses 795 652 693
Amortization of premiums and accretion of discounts associated with investments, net (1,044) (1,110) (1,141)
(Gains) losses on investments and from sales of businesses, net 363 (183) (560)
(Gains) losses on derivatives, net 3,610 8,779 1,371
(Income) loss from equity method investments, net of dividends or distributions 194 475 481
Interest credited to policyholder account balances 6,260 6,282 5,610
Universal life and investment-type product policy fees (7,708) (9,207) (9,507)
Goodwill impairment — 260 —
Change in fair value option and trading securities (436) 111 784
Change in accrued investment income (280) (31) 138
Change in premiums, reinsurance and other receivables (991) (2,158) (831)
Change in deferred policy acquisition costs and value of business acquired, net (693) (937) 488
Change in income tax (2,796) (1,522) 715
Change in other assets 691 3,248 2,752
Change in insurance-related liabilities and policy-related balances 8,511 6,321 6,408
Change in other liabilities 1,603 2,801 1,172
Other, net 184 139 94
Net cash provided by (used in) operating activities 12,283 14,774 14,052
Cash flows from investing activities
Sales, maturities and repayments of:
Fixed maturity securities 95,945 150,658 146,732
Equity securities 1,433 1,241 1,117
Mortgage loans 10,353 12,977 12,647
Real estate and real estate joint ventures 972 826 3,256
Other limited partnership interests 1,082 1,542 1,827
Purchases of:
Fixed maturity securities (105,683) (146,397) (148,799)
Equity securities (920) (1,006) (996)
Mortgage loans (14,374) (21,017) (20,449)
Real estate and real estate joint ventures (1,446) (1,515) (1,298)
Other limited partnership interests (1,486) (1,313) (1,429)
Cash received in connection with freestanding derivatives 5,315 4,259 2,690
Cash paid in connection with freestanding derivatives (8,696) (6,963) (4,211)
Cash received under repurchase agreements — — 199
Cash paid under repurchase agreements — — (199)
Cash received under reverse repurchase agreements — — 199
Cash paid under reverse repurchase agreements — — (199)
Cash disposed due to distribution of Brighthouse (663) — —
Sales of businesses, net of cash and cash equivalents disposed of $0, $135 and $0, respectively — 156 —
Purchases of businesses (211) — —
Purchases of investments in operating joint ventures — (39) —
Net change in policy loans (67) 195 287
Net change in short-term investments 2,087 1,270 (777)
Net change in other invested assets (171) (267) (936)
Other, net (346) (457) (59)
Net cash provided by (used in) investing activities $ (16,876) $ (5,850) $ (10,398)
See accompanying notes to the consolidated financial statements.
206